Experts discuss the latest data for emerging HER2-directed therapies in advanced breast cancer

touchPANEL DISCUSSION for touchONCOLOGY Listen as leading experts discuss the latest clinical data for emerging HER2-directed therapies and review novel therapeutic strategies and consider the implications for clinical practice. The experts Dr Laura Biganzoli – Department of Oncology, Hospital of Prato, Prato, Italy Dr Peter Fasching – Comprehensive Cancer Center, Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany Dr Sonia Pernas – Catalan Institute of Oncology, and Faculty of Medicine, University of Barcelona, Barcelona, Spain This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent educational grant from SeaGen. This activity is jointly provided by USF Health and touchIME. For further information visit our website:  https://touchoncologyime.org/expanding_options_her2_advanced_breast_cancer/